Skip to content
2000
Volume 4, Issue 2
  • ISSN: 0250-6882
  • E-ISSN: 0250-6882

Abstract

Background

Right ventricular hemangioma is very rare. Corona Virus disease (COVID-19) and vaccination were documented to cause diverse thromboembolic phenomena.

Case Presentation

We report a large right ventricular hemangioma presented as acute pulmonary embolism two weeks after COVID-19 vaccination associated with acute kidney injury and significantly elevated Interleukin-6 (IL-6). There was no thrombocytopenia; therefore, the diagnosis of vaccine-induced immune thrombotic thrombocytopenia (VIIT) was deemed unlikely. The patient underwent emergency cardiac surgery. The mass was excised through a right atriotomy, and tricuspid annuloplasty was done. IL-6 normalized after six days with resolution of acute kidney injury.

Conclusion

Pulmonary embolism is a rare presentation of the right ventricular hemangioma, and COVID-19 vaccination could play a role in this presentation. Cardiac hemangioma could be associated with high IL-6 that resolves with excision.

© 2023 The Author(s). Published by Bentham Science Publisher. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/nemj/10.2174/0250688204666230412085052
2023-06-13
2025-07-10
The full text of this item is not currently available.

References

  1. LiW. TengP. XuH. MaL. NiY. Cardiac hemangioma: A comprehensive analysis of 200 cases.Ann. Thorac. Surg.20159962246225210.1016/j.athoracsur.2015.02.06425921258
    [Google Scholar]
  2. KrishnaA. ConstantinM. Rare case of intramyocardial right ventricular outflow tract (RVOT) hemangioma.J. Am. Coll. Cardiol.20191273
    [Google Scholar]
  3. MalasM.B. NaazieI.N. ElsayedN. MathlouthiA. MarmorR. ClaryB. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis.EClinicalMedicine202029-3010063910.1016/j.eclinm.2020.10063933251499
    [Google Scholar]
  4. SuH. LeiC.T. ZhangC. Interleukin-6 signaling pathway and its role in kidney disease: An update.Front. Immunol.2017840510.3389/fimmu.2017.0040528484449
    [Google Scholar]
  5. LiX. ChenY. LiuJ. XuL. LiY. LiuD. SunZ. WenZ. Cardiac magnetic resonance imaging of primary cardiac tumors.Quant. Imaging Med. Surg.202010129431310.21037/qims.2019.11.1331956550
    [Google Scholar]
  6. BusselDBC SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia.N Engl J Med.2021384232254225610.1056/NEJMe210631533861524
    [Google Scholar]
  7. MendozaC.E. RosadoM.F. PachecoP. Interleukin-6 production and recurrent cardiac myxoma.J. Thorac. Cardiovasc. Surg.2001121239539610.1067/mtc.2001.10970411174750
    [Google Scholar]
  8. NeivaK.G. WarnerK.A. CamposM.S. ZhangZ. MorenJ. DanciuT.E. NörJ.E. Endothelial cell-derived interleukin-6 regulates tumor growth.BMC Cancer20141419910.1186/1471‑2407‑14‑9924533454
    [Google Scholar]
/content/journals/nemj/10.2174/0250688204666230412085052
Loading
/content/journals/nemj/10.2174/0250688204666230412085052
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test